This milestone follows the Company’s recent announcement of positive results from a 24-patient cohort treated with NEO100. The findings were presented to the investment community during NeOnc’s ...

NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”) , a multi–Phase 2 clinical-stage biopharmaceutical company developing novel therapies for central nervous system (CNS) cancers today ...

The latest announcement is out from NeOnc Technologies Holdings, Inc. ( ($NTHI) ). On November 7, 2025, NeOnc Technologies Holdings, Inc.

NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) ("NeOnc" or the "Company"), a multi-Phase 2 clinical-stage biopharmaceutical company pioneering therapies ...

It's the first sensation we feel, our most primal connection to others. Can implants and electrical signaling replicate the experience of touch? Research teams are exploring the possibilities—with ...

NeOnc Technologies Holdings, Inc. (NTHI) ("NeOnc" or the "Company"), a multi-Phase 2 clinical-stage biopharmaceutical company pioneering therapies ...

Laughing matters. It always has. But laughing may matter even more in modern times. Does anyone think that during the Middle ...

A similar proportion of eighth-graders failed to come up with the following sum: 12 + (-4) + 12 + 4 = _______. By the 12th ...

Approval based on results of landmark Phase 3 C-POST trial that show Libtayo is first immunotherapy to significantly improve disease-free survival in CSCC in the adjuvant setting, reducing the risk of ...

Laughing matters. It always has. But laughing may matter even more in modern times. Does anyone think that during the Middle ...

Explore the best self-care gifts we selected after testing over 400 products. There is something for everyone.

Consumers want solutions offering multifaceted benefits for sleep, stress, and cognitive function, putting retailers in ...